U.S. Markets closed

AAP Implantate AG (AAQ.DE)

XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
1.44-0.02 (-1.30%)
At close: 5:36PM CEST

AAP Implantate AG

Lorenzweg 5
Berlin 12099
49 30 75019 0

IndustryMedical Appliances & Equipment
Full Time Employees129

Key Executives

Mr. Bruke Seyoum Alemu Dipl.-Ing.Chairman of Mgmt. Board & Chief Exec. Officer335kN/A51
Mr. Marek HahnCFO & Member of Mgmt. Board237kN/A43
Nanette HüdepohlHead of Corp. CommunicationsN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


aap Implantate AG, a medical device company, develops, manufactures, and markets trauma products for orthopedics in Germany and the United States. The company offers LOQTEQ, an anatomical angular stable plating system for fracture treatment; and a range of cannulated screws, standard plates, and screws. It also offers bone substitutes, including Artosal, a synthetic osteoconductive bone substitute; Cerabone, a ceramic bone substitute; OsteoCem, a calcium phosphate cement; Osnatal, a high-quality human bone allograft; PerOssal, a fully synthetic bone substitute and carrier material; and Calcifix, a calcium phosphate cement, as well as collagen fleeces. The company sells its products directly to hospitals, buying syndicates, and hospital groups, as well as through a network of distributors under the aap brand name. aap Implantate AG was founded in 1990 and is headquartered in Berlin, Germany.

Corporate Governance

AAP Implantate AG’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.